Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A2B adenosine receptor antagonists
Graphical abstract
The potent and selective A2B adenosine receptor antagonist 9 was shown to have good oral bioavailability in the rat.
Section snippets
Acknowledgements
We thank Maria Isabel Loza and Maria Isabel Cadavid from the Universidad de Santiago de Compostela for performing the radioligand binding assays mentioned in this work.
References and notes (13)
Curr. Opin. Pharmacol.
(2003)J. Mol. Pharmacol.
(2005)- et al.
Inflamm. Res.
(1999) Br. J. Pharmacol.
(2005)- et al.
J. Clin. Invest.
(1995)
Cited by (19)
Pyrimidines and Their Benzo Derivatives
2021, Comprehensive Heterocyclic Chemistry IVA novel 2,4-diaminopyrimidine derivative as selective inhibitor of protein kinase C theta prevents allograft rejection in a rat heart transplant model
2018, Bioorganic and Medicinal ChemistryCitation Excerpt :Prevention of allograft rejection was assessed in an ACI-to-Lewis rat heterotopic cardiac allograft transplant model by oral administration of the compound. In vehicle-treated recipient Lewis rats, grafts from donor ACI rats were acutely rejected on postoperative day 6 (standard data in our lab).16 In the present study, oral administration of the PKCθ inhibitor 16c exhibited dose-dependent and effective prevention of allograft rejection to prolong graft survival time (MST = 11 days and 17 days at 10 and 30 mg/kg (bid), respectively).
Synthesis and pharmacological evaluation of 6-aminonicotinic acid analogues as novel GABA<inf>A</inf> receptor agonists
2014, European Journal of Medicinal ChemistryCitation Excerpt :The 2-substituted analogues 10–13 (Scheme 3) were prepared from 2,6-dichloropyridine using nucleophilic aromatic substitution under high pressure to form 6-chloro-2-aminopyridine (36) [24]. Subsequent regioselective iodination with N-iodosuccinimide (NIS) [25] and palladium catalyzed cyanation afforded the central intermediate 38 serving as cross-coupling partner for the formation of 2-substituted analogues 39–41. Ethyl and butyl groups were introduced via Negishi cross coupling with Et2Zn or BuZnBr [26], and the phenyl group was introduced using Suzuki cross coupling with phenylboronic acid.
Recent developments in adenosine receptor ligands and their potential as novel drugs
2011, Biochimica et Biophysica Acta - BiomembranesCitation Excerpt :PSB-1115 (64) exhibits high water-solubility and is therefore useful for in vivo studies, however its A2B affinity and selectivity is lower than that for other A2B antagonists. Besides xanthines, 2-aminopyrimidine derivatives, such as LAS38096 (69), 2-aminothiazolopyrimidines (e.g. 70), benzothiazoles (e.g. 71) [174], pyridine derivatives (e.g. 72, 73) [171,175], have been developed as A2B antagonists. Compound 72 was shown to be metabolically unstable.
Discovery of novel quinolinone adenosine A<inf>2B</inf> antagonists
2010, Bioorganic and Medicinal Chemistry Letters